Assays and stuff
Underwriting and stuff
Diagnoses and stuff
And I’m looking for a partner to optimize my workflow
And I need help cutting down on data entry mistakes
And I want the right tools to scale my business
Move fast. Speed is one of your main advantages over large competitors.
STUFF WE LOVE: SPEED, ACCURACY, EFFICIENCY, CONVENIENCE, GOOD COFFEE, PIZZA, LONG WALKS ON THE BEACH
STUFF WE HATE: LONG-WAIT TIMES, INCOMPLETE AND INACCURATE PAPERWORK, INEFFICIENCY, THINGS THAT REQUIRE A BATTERY SIZE THAT ISN’T AA, CLICKING ON A 20-SECOND VIDEO BUT HAVING TO WATCH A 45-SECOND COMMERCIAL FIRST
- STOP WASTING PRECIOUS TIME AND LET FROGMD HELP YOUR TEAM WITH SECURE, HIPAA COMPLIANT, REAL-TIME DOCUMENT SHARING SO THAT YOUR QUALITY CONTROL TEAM CAN RECEIVE AND VERIFY PAPERWORK BEFORE THE PATIENT EVER LEAVES THE OFFICE.
Fast is fine, but accuracy is everything.
STUFF WE LOVE: BEING ERROR-FREE, AUTOMATED DATA ENTRY, LESS PAPERWORK, BILLABLE TEST SAMPLES, KITTENS, ICE CREAM, BINGE WATCHING NETFLIX
STUFF WE HATE: MISTAKES, MANUAL DATA ENTRY, PAPERWORK, UNBILLABLE SAMPLES, PISTACHIOS THAT DON’T OPEN, PHONE AUTO-CORRECTING ‘HAGA’ INTO ‘GAGA’ INSTEAD OF ‘HAHA’
- STOP FILLING OUT ENDLESS STACKS OF PAPERWORK AND LET FROGMD MINIMIZE THE POTENTIAL FOR HUMAN ERROR, SO YOU CAN SLEEP EASY AT NIGHT KNOWING THAT YOUR BILLING DEPARTMENT IS ACTUALLY BILLING AND NOT WASTING TIME WITH DATA CORRECTION AND DENIED CLAIMS. OUR CLIENTS ENJOY A >95% BILLABLE SAMPLE RATE THE FIRST TIME, EVERY TIME.
Growth is never by mere chance; it is the result of forces working together.
STUFF WE LOVE: INCREASED REVENUE, BUSINESS INSIGHTS, AUTOMATED MARKETING, MAC-N-CHEESE, FRESHLY BAKED COOKIES, FINDING MONEY WE FORGOT ABOUT
STUFF WE HATE: STAGNANT REVENUE GROWTH, INABILITY TO MEASURE RESULTS, OUTDATED MARKETING TOOLS, SOGGY BURGER BUNS, SOCKS THAT ARE JUST A LITTLE TOO BIG, WHEN THE COMPUTER SAYS YOU HAVE WIFI, BUT THE BROWSER SAYS ‘NO INTERNET CONNECTION’
- STOP LIVING IN THE PAST, AND LET FROGMD HELP YOU BOOST REVENUE, TRACK YOUR BUSINESS AND EXPAND YOUR REACH WITH CUTTING-EDGE BUSINESS ANALYTICS, SMS AND EMAIL MARKETING WITH FIELD-PROVEN TECHNOLOGY
Treatment without prevention is simply unsustainable.
FROGMD IS DEDICATED TO EXPANDING ACCESS TO HEREDITARY CANCER RISK ASSESSMENT. OUR PROPRIETARY SYSTEM CAN HELP IDENTIFY YOUR PATIENT’S RISK FOR DEVELOPING CANCER IN HIS OR HER LIFETIME.
CURRENTLY THERE IS LIMITED ACCESS TO THIS TYPE OF TESTING, AND AS SUCH, MILLIONS OF PEOPLE ARE WALKING AROUND WITHOUT KNOWING THEIR PERSONAL RISK PROFILE.
- FACT: ABOUT 1 IN 3 PEOPLE IN THE UNITED STATES WILL DEVELOP CANCER DURING THEIR LIFETIME
- FACT: PREDICTIVE RISK TESTING SHOULD BE CONSIDERED IF THERE IS A HISTORY OF EARLY-ONSET CANCER IN THE FAMILY
- FACT: PROVIDERS CAN BE HELD LIABLE FOR NOT OFFERING RISK TESTING
OUR PROPRIETARY TECHNOLOGY IS A COMPLETELY FREE, STAND-ALONE TOOL AVAILABLE TO ALL HEALTHCARE PROFESSIONALS, AND CAN ALSO BE COUPLED WITH OUR GENETIC COUNSELING AND TESTING PARTNERS.
KNOWLEDGE IS POWER, AND TOGETHER WE CAN SAVE LIVES
There are risks and costs to action. But they are far less than the long-range risks of comfortable inaction.
FROGMD IS DEDICATED TO EXPANDING ACCESS TO HEREDITARY CANCER RISK TESTING. OUR PROPRIETARY SYSTEM CAN HELP IDENTIFY THE RIGHT PATIENTS FOR TESTING, BASED ON YOUR SPECIFIC RISK CRITERIA, EVERY TIME.
DUE TO COMPLEX AND EVER-CHANGING CRITERIA, YOUR TEAM HAS TO DEAL WITH MANY PATIENTS THAT DO NOT MEET RISK CRITERIA FOR TESTING, COSTING YOU TIME AND MONEY AND ULTIMATELY MAKING IT HARDER FOR THE RIGHT PATIENTS TO GET THE COVERAGE THEY NEED.
- FACT: BY 2020 THERE WILL BE 18.3 MILLION CANCER SURVIVORS, WITH ASSOCIATED COSTS OF CANCER CARE OF 157.77 BILLION
- FACT: CANCER DRUGS COST AN AVERAGE OF $10,000 PER MONTH, WITH SOME THERAPIES TOPPING $30,000 PER MONTH
- FACT: INSURANCE PLANS WILL FOOT MOST OF THE BILL
SAVE TIME AND MONEY WITH OUR PROPRIETARY TECHNOLOGY, ENSURING THAT EACH AND EVERY GENETIC TESTING CLAIM YOU RECEIVE EXACTLY MATCHES YOUR APPROVAL CRITERIA.
BEING PROACTIVE INSTEAD OF REACTIVE CAN SAVE LIVES AND YOUR BOTTOM LINE.
- Family Cancer Syndromes
Cancer is such a common disease that it is no surprise that many families have at least a few members who have had cancer. Sometimes, certain types of cancer seem to run in some families. But only a small portion of all cancers are inherited. This document focuses on those cancers.
- The Next Malpractice Crisis?
"The millions of patients who meet criteria for genetic testing but who have not been tested represent a level of financial exposure that could easily overwhelm the insurance industry."
- Cost of Cancer Care
Projections of the cost of cancer care in the United States: 2010-2020
- More Cost Projections
Cancer Prevalence and Cost of Care Projections
- Oncologists Take On Rising Costs
A task force of doctors has proposed a system to help patients better manage cancer costs
- Lynch Syndromes GeneReviews
Kohlmann W, Gruber SB. Lynch Syndrome. 2004 Feb 5 [Updated 2018 Feb 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.